Please see below for a list of search results.
The law on cryonics: who makes the decision, is there an age limit, are there plans to change the law and what happens to my body if the organisation goes bankrupt?
The cryonics process; making arrangements, what you can expect and what happens to your body.
Cryonics, cryopreservation and cryogenics - what do these terms mean and what is the difference?
The Human Tissue Authority (HTA) has produced this information to provide an overview of cryonics - the cryopreservation of whole bodies. We have worked with our public panel to find out what questions the public has about cryonics, and we have tried to answer those questions here.
A list of qualifying regulatory provisions and a summary of non-qualifying regulatory provisions for the reporting period 8 May 2015 to 8 June 2017 can be found below:
HTA Regulator Qualifying Regulatory Provisions Summary
Under the Enterprise Act 2016, the HTA and all other statutory regulators have a duty to report against the Government’s Business Impact Target. The target for the 2015-2020 Parliament is a £10 billion reduction in the cost of regulation to business.
The Authority is made up of a Chair and eleven Members:
To ensure that the HTA’s regulatory approach remains relevant, we actively prepare for the future. We do this through our development activities.
Our regulatory approach aims to be right-touch and in line with the principles of better regulation and the Regulators’ Code. This means that we primarily focus our regulation and resources on areas that involve an inherently greater risk to patient safety and public confidence if standards are...